September 2014
Studies on Synthesis and Biological Activity of Oxidative Aglafolin Derivatives
1433
55.7, 55.2, 54.1, 52.2, 52.1, 51.4. IR (cmꢀ1): 2953, 1746, 1707,
1620, 1594, 1510, 1255, 1219, 1156, 1124, 841, 816, 698.
6.16 (s, 1H), 5.96 (d, 1H, J = 1.8 Hz), 6.24 (d, 1H, J = 1.8 Hz),
6.62–6.67 (m, 2H), 7.15–7.24 (m, 3H), 7.29–7.34 (m, 4H).
13C NMR: d 200.7, 170.6, 162.1, 158.9, 156.4, 115.1, 130.9,
129.9, 129.2, 127.7, 127.4, 127.2, 126.4, 113.8, 101.5, 95.5,
92.9, 77.4, 77.0, 76.5, 75.9, 61.4, 55.8, 55.4, 55.2, 53.0, 52.9,
51.5, 50.9. IR (cmꢀ1): 3249, 1739, 1681, 1605, 1384, 1259,
1144, 1095, 812, 708. HRMS m/z: 491.1729 (M + H, Calcd for
2b (Trans): 0.85g, 16.3% yield, mp 168–169ꢁC. 1H NMR
(CDCl3): d 3.29 (s, 3H), 3.54 (s, 3H), 3.67 (s, 3H), 3.84 (s, 3H),
3.88 (s, 3H), 4.21 (d, 1H, J = 9.3Hz), 4.47 (d, 1H, J = 9.3 Hz),
5.97 (d, 1H, J = 1.8Hz ), 6.27 (d, 1H, J = 1.8Hz), 6.63–6.67 (m,
2H), 7.04–7.11(m, 3H), 7.17–7.21 (m, 2H), 7.36–7.42 (m, 2H).
13C NMR: d 194.5, 174.0, 169.8, 167.8, 167.6, 159.2, 159.1,
136.2, 130.2, 128.4, 127.4, 127.0, 126.9, 113.2, 104.3, 93.2, 92.7,
88.8, 55.9, 55.1, 53.4, 52.5, 52.1, 52.0. IR (cmꢀ1): 2953, 2841,
1785, 1623, 1592, 1511, 1254, 1221, 1159, 1032, 927, 818, 698.
Synthesis of 3. (1) 3a and 3b: To the reactant of metal Sm
(1.20 g, 8.0 mmol) in a flame-dried, three-necked round-bottom
flask (100 mL) equipped with a stir bar, septum, and nitrogen
inlet was added a solution of C2H4I2 (1.10 g, 3.9 mmol) in THF
(7 mL). After stirring for 1 h, the solution changed to blue, and
the reaction was continued for 3 h under ultrasound irradiation.
Anhydrous benzene (20 mL) was then added, and the reaction
was continued for an additional 2 h. A solution of 2a (1.02 g,
1.96 mmol) in benzene (100 mL) was added, and the reaction
was allowed to proceed for 10 h under ultrasound irradiation.
The reaction was quenched with the addition of HCl (1 M,
20 mL), and the solution was extracted with CH2Cl2
(3 ꢂ 30 mL). The combined organic phase was washed with
brine (2 ꢂ 20 mL), dried with anhydrous Na2SO4, and
concentrated. The crude product was purified by silica-gel column
chromatography (petroleum ether/EtOAc, 2:3) to afford a couple of
C
28H27O8, 491.1738).
Synthesis of 4.
anhydrous methanol (10 mL) was added
To a solution of 3a(0.1 g, 0.20 mmol) in
solution of
a
NH2NH2.H2O (0.013 g, 0.22 mmol) in methanol (2 mL). The
mixture was refluxed for 6 h and left to stand at room
temperature overnight and was then filtered to afford colorless
solid 0.078 g (82.6%), mp: 280–282ꢁC.1H NMR (CDCl3) d:
3.49 (s, 1H), 3.66 (s, 3H), 3.81 (s, 3H), 3.84 (s, 3H), 4.94
(s, 1H, ), 6.07 (d, 1H, J = 1.9 Hz), 6.31 (d, 1H, J = 1.9 Hz),
6.58–6.61 (m, 2H), 7.03–7.28 (m, 8H,). 13C NMR d: 164.1,
160.7, 158.8, 157.4, 137.5, 128.7, 127.8, 127.7, 126.8, 126.4,
113.0, 112.8, 107.0, 92.6, 89.3, 83.7, 64.3, 55.7, 55.0, 54.9.
IR (cmꢀ1): 3189, 1609, 1514, 1456, 1252, 1150, 1113, 1037,
1019, 811, 764, 700. HRMS m/z: 473.17031 (M+ H, Calcd for
C27H25N2O6, 473.17071).
Synthesis of 5.
To a solution of 3a (0.1 g, 0.20 mmol) in
anhydrous methanol (10 mL) was added a solution of phenyl
hydrazine (0.023g, 0.22 mmol) in methanol (3 mL). The mixture
was refluxed for 10h and left to stand at room temperature
overnight and was then filtered to afford red solid 0.07 g (60.3%
1
yield), mp 210–212ꢁC. H NMR (CDCl3) d: 3.66 (s, 3H), 3.70
diastereoisomers 3a and 3b.
1
3a: 0.27 g, yield: 28.6%. mp 161–162ꢁC. H NMR (CDCl3):
(s, 3H), 3.75 (s, 3H), 3.86 (s, 3H), 4.00 (d, 1H, J = 12.2 Hz), 4.35
(d, 1H, J = 12.2Hz ), 6.10 (d, 1H, J = 1.9Hz), 6.34 (d, 1H,
J = 1.9 Hz), 6.65–6.68 (m, 2H), 6.94–7.24 (m, 11H,), 7.26–7.34
(m, 2H). 13C NMR: d 171.8, 164.3, 160.4, 159.1, 157.5, 145.2,
138.0, 136.0, 129.2, 128.1, 127.9, 126.9, 125.7, 119.6, 113.5,
112.3, 101.4, 92.9, 90.2, 86.8, 56.1, 55.7, 55.1, 53.0, 52.4, 51.1.
IR (cmꢀ1): 3435, 2937, 1738, 1600, 1516, 1384, 1253, 1151,
1019, 805, 749, 696. HRMS m/z: 581.22825 (M+ H, Calcd for
C34H33N2O7, 581.22823).
d 3.04 (s, 1H), 3.66 (s, 3H), 3.71 (s, 3H), 3.81 (s, 3H), 3.85
(s, 3H), 4.06 (d, 1H, J = 13.2 Hz), 4.24 (d, 1H, J = 13.2 Hz),
6.10 (d, 1H, J = 1.8 Hz), 6.35 (d, 1H, J = 1.8 Hz), 6.66–6.70
(m, 2H), 6.89–6.97 (m, 4H), 7.08–7.12 (m, 3H). 13C NMR: d
203.3, 167.2, 164.9, 161.0, 158.9, 158.6, 135.4, 129.1, 128.0,
127.9, 127.7, 127.1, 125.4, 113.2, 112.2, 106.1, 99.3, 92.9,
89.9, 88.5, 56.4, 55.7, 55.6, 55.1, 55.0, 52.9, 52.0, 51.5. IR
(cmꢀ1): 3420, 2980, 1760, 1720, 1620, 1600, 1520, 1480,
1260, 1230, 1180, 1160, 1120, 1100, 1020, 820, 710. HRMS
m/z: 491.1685 (M + H, Calcd for C28H27O8, 491.1738). 3b:
Synthesis of 6.
To a solution of 3a (0.1 g, 0.20 mmol)
in anhydrous methanol (10 mL) was added a solution of
hydroxylamine hydrochloride (0.017 g, 0.25 mmol) in methanol
(2 mL). The mixture was refluxed for 12 h, and then the solvent
was evaporated and separated by column chromatography
(petroleum/ethyl acetate as eluent) to afford red solid 0.07 g
(60.3% yield), mp 203–205ꢁC.
1H NMR (CDCl3) d: 2.98 (s, 3H), 3.51 (s, 3H), 3.74 (s, 3H),
3.87 (s, 3H), 3.80 (d, 1H, J = 13.2 Hz), 4.20 (d, 1H, J = 13.2 Hz ),
6.19 (d, 1H, J = 1.9 Hz), 6.32 (d, 1H, J = 1.9 Hz), 6.67–6.70
(m, 2H), 6.82–7.10 (m, 7H,). 13C NMR d: 171.0, 164.4, 161.1,
160.0, 158.8, 157.3, 134.9, 128.3, 128.0, 127.8, 127.7, 127.1,
126.2, 113.1, 103.5, 99.0, 93.0, 91.4, 89.4, 71.7, 64.3, 55.9,
55.8, 55.7, 55.6, 52.5, 52.3, 47.2. IR (cmꢀ1): 3205, 2948,
1736, 1613, 1598, 1518, 1384, 1252, 1116, 1046, 974, 838,
814, 700. HRMS m/z: 520.19624 (M + H, Calcd for
C29H30NO8, 520.19659); 542.17786 (M + Na, Calcd for
C29H29N2O8Na, 542.17854).
1
0.10 g, yield: 10.5%. mp 196–198ꢁC. H NMR(CDCl3): d 3.17
(s, 1H), 3.67 (s, 3H), 3.72 (s, 3H), 3.80 (s, 3H), 3.81 (s, 3H),
4.93 (s, 1H), 5.60 (s, 1H), 6.10 (d, 1H, J = 1.8 Hz), 6.35
(d, 1H, J = 1.8 Hz), 6.65–6.68 (m, 2H), 7.15–7.24 (m, 3H),
7.29–7.35 (m, 4H). 13C NMR: d 200.8, 170.5, 162.1, 158.9,
156.4, 130.4, 129.2, 129.0, 127.6, 127.4, 127.2, 126.4, 113.8,
101.5, 95.6, 92.9, 77.4, 77.0, 76.5, 75.9, 61.4, 55.8, 55.4, 55.2,
53.0, 52.9, 51.6, 50.9. IR (cmꢀ1): 3429, 1739, 1682, 1604, 1384,
1259, 1201, 1144, 1096, 852, 707. HRMS m/z: 491.1742 (M+ H,
Calcd for C28H27O8, 491.1738).
(2) 3c and 3d: Following the same procedure as previously
mentioned, starting from 2b to prepare 3c and 3d.
1
3c: 0.25 g, yield: 26.2%, mp 95–96ꢁC. H NMR (CDCl3): d
2.95 (s, 1H), 3.42 (s, 3H), 3.49 (s, 3H), 3.61 (s, 3H), 3.63
(s, 3H), 4.08 (d, 1H, J = 13.0 Hz), 4.16 (d, 1H, J = 13.0 Hz),
5.30 (d, 1H, J = 1.8 Hz), 5.60 (d, 1H, J = 1.8 Hz), 6.63–6.67
(m, 2H), 6.90–7.01 (m, 4H), 7.08–7.65 (m, 3H). IR (cmꢀ1):
3400, 2980, 1770, 1720, 1600, 1500, 1480, 1430, 1420, 1350,
1260, 1220, 1150, 1120, 820, 710. HRMS m/z: 491.1735
(M + H, Calcd for C28H27O8, 491.1738). 3d, 0.12 g, yield:
BIOASSAY
1
12.5%. mp 163–164ꢁC. H NMR (CDCl3): d 3.17(s, 1H), 3.68
Azadirachtin and the newly synthesized compounds
were individually dissolved in chloroform (1% M/V) and
(s, 3H), 3.71 (s, 3H), 3.80 (s, 3H), 3.81 (s, 3H), 4.95 (s, 1H),
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet